Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.35
+0.74 (8.59%)
Mar 26, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $342.52 million as of March 26, 2026. Its market cap has increased by 400.86% in one year.
Market Cap
342.52M
Enterprise Value
621.85M
1-Year Change
400.86%
Ranking
Category
Stock Price
$9.35
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $342.52M, an increase of 639.55%. That is a compound annual growth rate of 33.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 340.40M | 48.89% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 331.77M |
| Forte Biosciences | 330.46M |
| Bicycle Therapeutics | 326.23M |
| Crescent Biopharma | 322.41M |
| Puma Biotechnology | 322.05M |
| Avalo Therapeutics | 317.90M |
| Ovid Therapeutics | 316.50M |
| Cabaletta Bio | 309.48M |